(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are LAVIDE HOLDING, EQVA, and AZERION.

The three biggest losers today are DMS IMAGING, NAPATECH, and HOTELS DE PARIS.

Winners today

1. LAVIDE HOLDING (LVIDE.AS) – 47.37%

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING rising 47.37% to €0.28 on Tuesday while AEX-Index dropped 0.54% to €752.93.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.025.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LAVIDE HOLDING’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for LAVIDE HOLDING is 142555 which is 783.73% above its average volume of 16131.

More news about LAVIDE HOLDING.

2. EQVA (EQVA.OL) – 31.72%

Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA rising 31.72% to €3.82 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.3% to €1,240.92.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EQVA’s stock is considered to be oversold (<=20).

More news about EQVA.

3. AZERION (AZRN.AS) – 19.19%

Azerion Group N.V. operates a digital entertainment and media platform worldwide. Its integrated platform provides technology solutions to automate the purchase and sale of digital advertising inventory for advertisers, publishers, and game creators, as well as to develop, publish, distribute, and operate online social and casual games, and digital content. The company was founded in 2014 and is headquartered in Schiphol-Rijk, the Netherlands. Azerion Group N.V. is a subsidiary of Principion Holding B.V.

AEX-Index ended the session with AZERION jumping 19.19% to €3.54 on Tuesday while AEX-Index dropped 0.54% to €752.93.

Earnings Per Share

As for profitability, AZERION has a trailing twelve months EPS of €-167.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -241.46%.

Yearly Top and Bottom Value

AZERION’s stock is valued at €3.54 at 21:40 EST, way below its 52-week high of €9.50 and way higher than its 52-week low of €2.56.

Moving Average

AZERION’s worth is way under its 50-day moving average of €4.03 and way below its 200-day moving average of €6.39.

Revenue Growth

Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 430.15M for the twelve trailing months.

Volume

Today’s last reported volume for AZERION is 1209850 which is 296.24% above its average volume of 305327.

More news about AZERION.

4. AUGROS COSMETICS (AUGR.PA) – 15.27%

Augros Cosmetic Packaging SA provides customized packaging solutions in France. The company offers decoration solutions for glass, plastic, and aluminum packaging materials. It serves the perfume, cosmetic, and spirit industries. The company is based in Alencon, France. Augros Cosmetic Packaging SA operates as a subsidiary of Famille Bourgine.

CAC 40 ended the session with AUGROS COSMETICS rising 15.27% to €7.55 on Tuesday, after five consecutive sessions in a row of losses. CAC 40 slid 0.38% to €7,267.93, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, AUGROS COSMETICS has a trailing twelve months EPS of €-0.47.

Volume

Today’s last reported volume for AUGROS COSMETICS is 44 which is 92.75% below its average volume of 607.

More news about AUGROS COSMETICS.

5. OCEANTEAM (OTS.OL) – 12.78%

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, handling of subsea cables, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable carousels, and other cable handling equipment. It serves renewable, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM jumping 12.78% to €1.50 on Tuesday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.3% to €1,240.92, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-11.078.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.71%.

Volatility

OCEANTEAM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.88%, a negative 0.67%, and a positive 2.66%.

OCEANTEAM’s highest amplitude of average volatility was 2.87% (last week), 2.71% (last month), and 2.66% (last quarter).

Moving Average

OCEANTEAM’s value is under its 50-day moving average of kr1.58 and way under its 200-day moving average of kr2.41.

Revenue Growth

Year-on-year quarterly revenue growth declined by 57.7%, now sitting on 3.74M for the twelve trailing months.

More news about OCEANTEAM.

6. FIN.OUEST AFRICAIN (FOAF.PA) – 9.38%

Fin.Ouest Africain provides various financial services. It offers car, personal, business risk, transportation, and other property and casualty insurance products; and life insurance products for individuals, private and public companies, and organizations. It also invests in bonds and shares in listed and unlisted companies; and provides wealth management services, including building and managing real estate assets. The company was founded in 1951 and is based in Dakar, Senegal.

CAC 40 ended the session with FIN.OUEST AFRICAIN rising 9.38% to €35.00 on Tuesday while CAC 40 dropped 0.38% to €7,267.93.

More news about FIN.OUEST AFRICAIN.

7. SIEM OFFSHORE (SIOFF.OL) – 7.95%

Siem Offshore Inc., together with its subsidiaries, owns and operates offshore support vessels for the offshore energy service industry and offshore renewables market. It operates platform supply vessels (PSVs); offshore subsea construction vessels (OSCVs); anchor-handling tug supply vessels (AHTS vessels); multipurpose field and ROV support vessels; scientific core drilling vessels (SCDVs); well intervention vessels (WIVs); and other vessels, including fast crew, fast supply, and oilspill recovery vessels. The company has a fleet of 28 vessels, which includes six PSVs, four OSCVs, eight AHTS vessels, two WIVs, one SCDV, five smaller Brazilian flagged vessels, and one Canadian flagged vessel comprising an AHTS vessel. It operates in Norway, North Sea, Brazil, Australia, Canada, the Arctic Ocean, Northern Pacific Ocean, Southeast Asia, and West Africa. The company was founded in 2005 and is headquartered in Kristiansand, Norway.

Oslo Børs Benchmark Index_GI ended the session with SIEM OFFSHORE rising 7.95% to €15.76 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.3% to €1,240.92.

Earnings Per Share

As for profitability, SIEM OFFSHORE has a trailing twelve months EPS of kr-2.66.

Moving Average

SIEM OFFSHORE’s worth is above its 50-day moving average of kr15.13 and way above its 200-day moving average of kr13.33.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SIEM OFFSHORE’s EBITDA is 248.39.

More news about SIEM OFFSHORE.

8. BENEVOLENTAI (BAI.AS) – 7.69%

BenevolentAI société anonyme operates as a clinical-stage AI-enabled drug discovery company. The company's BenevolentAI platform powers a pipeline of approximately 20 drug programs. BenevolentAI société anonyme was formerly known as BenevolentAI Limited and changed its name to BenevolentAI société anonyme on April 22, 2022. The company is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI rising 7.69% to €2.80 on Tuesday while AEX-Index fell 0.54% to €752.93.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-1.56.

Volatility

BENEVOLENTAI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.14%, a negative 2.24%, and a positive 5.13%.

BENEVOLENTAI’s highest amplitude of average volatility was 8.85% (last week), 5.57% (last month), and 5.13% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BENEVOLENTAI’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

BENEVOLENTAI’s stock is valued at €2.80 at 21:40 EST, way below its 52-week high of €10.00 and way above its 52-week low of €2.50.

More news about BENEVOLENTAI.

9. AB SCIENCE (AB.PA) – 6.83%

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE jumping 6.83% to €6.57 on Tuesday, following the last session’s upward trend. CAC 40 fell 0.38% to €7,267.93, after two successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.23.

More news about AB SCIENCE.

10. MOREFIELD GROUP (MORE.AS) – 6.67%

Morefield Group N.V. does not have significant operations. Previously, the company was involved in the external professionals hiring activities. The company was formerly known as HeadFirst Source Group N.V. and changed its name to Morefield Group N.V. in January 2019. Morefield Group N.V. is based in Willemstad, Curaçao.

AEX-Index ended the session with MOREFIELD GROUP jumping 6.67% to €0.32 on Tuesday while AEX-Index fell 0.54% to €752.93.

Earnings Per Share

As for profitability, MOREFIELD GROUP has a trailing twelve months EPS of €0.001.

PE Ratio

MOREFIELD GROUP has a trailing twelve months price to earnings ratio of 320. Meaning, the purchaser of the share is investing €320 for every euro of annual earnings.

Volume

Today’s last reported volume for MOREFIELD GROUP is 6459 which is 36.78% above its average volume of 4722.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MOREFIELD GROUP’s stock is considered to be overbought (>=80).

More news about MOREFIELD GROUP.

Losers Today

1. DMS IMAGING (DMSIM.BR) – -16.94%

DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen. The company is also developing hdm-ASIT+ for the treatment of house dust mite allergy; and pnt-ASIT+ for the treatment of peanut allergy. The company was formerly known as ASIT Biotech S.A. and changed its name to DMS Imaging SA in February 2022. DMS Imaging SA was incorporated in 1997 and is based in Liege, Belgium.

BEL 20 ended the session with DMS IMAGING falling 16.94% to €0.03 on Tuesday, following the last session’s upward trend. BEL 20 dropped 0.16% to €3,902.21, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for DMS IMAGING is 76579 which is 58.07% below its average volume of 182667.

Volatility

DMS IMAGING’s last week, last month’s, and last quarter’s current intraday variation average was 7.46%, 0.59%, and 7.52%.

DMS IMAGING’s highest amplitude of average volatility was 11.14% (last week), 5.74% (last month), and 7.52% (last quarter).

More news about DMS IMAGING.

2. NAPATECH (NAPA.OL) – -12.59%

Napatech A/S provides reconfigurable computing solutions for the network management and cybersecurity applications worldwide. The company offers Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which provides a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions on SmartNIC platform, as well as Link-Assure professional services. It also provides solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. The company was incorporated in 2003 and is headquartered in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH dropping 12.59% to €10.14 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.3% to €1,240.92.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-0.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.3%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NAPATECH’s EBITDA is -216.33.

More news about NAPATECH.

3. HOTELS DE PARIS (HDP.PA) – -8.22%

Les Hôtels de Paris SA operates and manages hotels in Paris. As of December 31, 2021, it operated 17 hotels in Paris, 1 hotel in St Tropez, and 1 hotel in Marrakech. The company was incorporated in 1992 and is headquartered in Paris, France.

CAC 40 ended the session with HOTELS DE PARIS falling 8.22% to €1.34 on Tuesday, after four consecutive sessions in a row of losses. CAC 40 fell 0.38% to €7,267.93, after two consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, HOTELS DE PARIS has a trailing twelve months EPS of €-2.341.

Volume

Today’s last reported volume for HOTELS DE PARIS is 1439 which is 352.51% above its average volume of 318.

Volatility

HOTELS DE PARIS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.02%, a positive 1.59%, and a positive 6.86%.

HOTELS DE PARIS’s highest amplitude of average volatility was 1.02% (last week), 3.98% (last month), and 6.86% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HOTELS DE PARIS’s stock is considered to be overbought (>=80).

More news about HOTELS DE PARIS.

4. BW ENERGY LIMITED (BWE.OL) – -6.68%

BW Energy Limited engages in the acquisition, exploration, development, and production of oil and natural gas in West Africa and Brazil. It primarily holds interests in three hydrocarbon licenses located in Dussafu, Gabon; Maromba, Brazil; and Kudu, Namibia. The company was founded in 2016 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with BW ENERGY LIMITED dropping 6.68% to €29.06 on Tuesday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.3% to €1,240.92, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, BW ENERGY LIMITED has a trailing twelve months EPS of kr-1.49.

Volatility

BW ENERGY LIMITED’s last week, last month’s, and last quarter’s current intraday variation average was 0.62%, 0.44%, and 1.59%.

BW ENERGY LIMITED’s highest amplitude of average volatility was 2.41% (last week), 1.69% (last month), and 1.59% (last quarter).

More news about BW ENERGY LIMITED.

5. NYRSTAR (NYR.BR) – -5.04%

Nyrstar NV engages in mining, smelting, and producing zinc, lead, and other base and precious metals primarily in Europe, Australia, Canada, and the United States. The company operates in Metals Processing and Mining segments. It offers zinc in concentrate from its mining operations; and refined market zinc products, including special high grade zinc, zinc galvanizing alloys, and zinc die-casting alloys for various applications and uses, such as construction and infrastructure, transport, industrial machinery, communications, electronics, and consumer products. The company also produces copper in concentrates and copper cathodes used in building construction, electrical and electronic products, transportation equipment, consumer products, and industrial machinery and equipment; and lead in concentrate primarily for the production of batteries. In addition, it offers gold and silver in concentrate and dore; indium and cadmium; and sulphuric acid for the production of fertilizers, fibers, paints, rubber, plastics, steel, detergents, and medicines. Nyrstar NV was founded in 2007 and is based in Zurich, Switzerland.

BEL 20 ended the session with NYRSTAR dropping 5.04% to €0.12 on Tuesday while BEL 20 slid 0.16% to €3,902.21.

Earnings Per Share

As for profitability, NYRSTAR has a trailing twelve months EPS of €-7.066.

More news about NYRSTAR.

6. POXEL (POXEL.PA) – -5.04%

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH). Poxel S.A. has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. The company was incorporated in 2009 and is headquartered in Lyon, France.

CAC 40 ended the session with POXEL dropping 5.04% to €0.66 on Tuesday, after four consecutive sessions in a row of losses. CAC 40 dropped 0.38% to €7,267.93, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, POXEL has a trailing twelve months EPS of €-0.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -323.36%.

Volume

Today’s last reported volume for POXEL is 92581 which is 39.44% above its average volume of 66391.

Revenue Growth

Year-on-year quarterly revenue growth declined by 99.4%, now sitting on 206k for the twelve trailing months.

Volatility

POXEL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.04%, a negative 1.95%, and a positive 2.44%.

POXEL’s highest amplitude of average volatility was 6.04% (last week), 2.54% (last month), and 2.44% (last quarter).

Yearly Top and Bottom Value

POXEL’s stock is valued at €0.66 at 21:40 EST, under its 52-week low of €0.67.

More news about POXEL.

7. CASINO GUICHARD (CO.PA) – -5.02%

Casino, Guichard-Perrachon S.A. operates as a food retailer in France and internationally. The company operates hypermarkets, supermarkets, shopping centers, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also offers private label products. In addition, the company is involved in banking, digital marketing and advertising, service station, restaurant, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates 10,800 stores. The company was founded in 1898 and is based in Saint-Étienne, France.

CAC 40 ended the session with CASINO GUICHARD sliding 5.02% to €9.47 on Tuesday, following the last session’s upward trend. CAC 40 dropped 0.38% to €7,267.93, after two successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-4.79.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.37%.

Sales Growth

CASINO GUICHARD’s sales growth for the next quarter is negative 11.2%.

Moving Average

CASINO GUICHARD’s value is way under its 50-day moving average of €10.94 and way under its 200-day moving average of €11.79.

Yearly Top and Bottom Value

CASINO GUICHARD’s stock is valued at €9.47 at 21:40 EST, way under its 52-week high of €19.27 and way above its 52-week low of €7.32.

More news about CASINO GUICHARD.

8. MALTERIES FCO-BEL. (MALT.PA) – -4.72%

Malteries Franco-Belges Société Anonyme engages in the production and sale of malt primarily for brewers in France and internationally. It also trades in barley. The company is headquartered in Nogent-sur-Seine, France. Malteries Franco-Belges Société Anonyme is a subsidiary of Malteries Soufflet SAS.

CAC 40 ended the session with MALTERIES FCO-BEL. dropping 4.72% to €605.00 on Tuesday while CAC 40 slid 0.38% to €7,267.93.

Earnings Per Share

As for profitability, MALTERIES FCO-BEL. has a trailing twelve months EPS of €34.75.

PE Ratio

MALTERIES FCO-BEL. has a trailing twelve months price to earnings ratio of 17.41. Meaning, the purchaser of the share is investing €17.41 for every euro of annual earnings.

Volume

Today’s last reported volume for MALTERIES FCO-BEL. is 1 which is 92.85% below its average volume of 14.

More news about MALTERIES FCO-BEL..

9. NYKODE THERAPEUTIC (NYKD.OL) – -4.58%

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of melanoma, lung, head and neck, renal, and bladder cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, and Nektar Therapeutics; Adaptive Biotechnologies for COVID-19 T cell vaccine development; and research agreement with Regeneron. The company was formerly known as Vaccibody AS. Nykode Therapeutics AS was founded in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NYKODE THERAPEUTIC sliding 4.58% to €25.86 on Tuesday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.3% to €1,240.92, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, NYKODE THERAPEUTIC has a trailing twelve months EPS of kr4.4.

PE Ratio

NYKODE THERAPEUTIC has a trailing twelve months price to earnings ratio of 5.87. Meaning, the purchaser of the share is investing kr5.87 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.01%.

Yearly Top and Bottom Value

NYKODE THERAPEUTIC’s stock is valued at kr25.86 at 21:40 EST, way under its 52-week high of kr48.70 and way above its 52-week low of kr22.50.

Volatility

NYKODE THERAPEUTIC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.10%, a negative 0.57%, and a positive 2.65%.

NYKODE THERAPEUTIC’s highest amplitude of average volatility was 3.10% (last week), 2.13% (last month), and 2.65% (last quarter).

Sales Growth

NYKODE THERAPEUTIC’s sales growth for the current quarter is negative 96.3%.

Volume

Today’s last reported volume for NYKODE THERAPEUTIC is 355957 which is 33.45% below its average volume of 534874.

More news about NYKODE THERAPEUTIC.

10. HAFNIA LIMITED (HAFNI.OL) – -4.49%

Hafnia Limited owns and operates oil product tankers. The company operates through four segments: Long Range II (LR2), Long Range I (LR1), Medium Range (MR), and Handy size (Handy). It transports petroleum oil products, vegetable oil, and easy chemicals to national and international oil companies, and chemical companies, as well as trading and utility companies. The company provides ship owning, ship-management, chartering, investment, and agency office services. As of March 29, 2022, it operated a fleet of 237 vessels, including newbuilds, of which 145 are owned or chartered-in, including 10 owned LR2s, 40 owned and chartered-in LR1s, 58 owned and chartered-in MRs, and 29 owned Handy and eight stainless steel 25K vessels. The company is based in Hamilton, Bermuda. Hafnia Limited is a subsidiary of BW Group Limited.

Oslo Børs Benchmark Index_GI ended the session with HAFNIA LIMITED sliding 4.49% to €63.80 on Tuesday, after three successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.3% to €1,240.92, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, HAFNIA LIMITED has a trailing twelve months EPS of kr9.67.

PE Ratio

HAFNIA LIMITED has a trailing twelve months price to earnings ratio of 6.6. Meaning, the purchaser of the share is investing kr6.6 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.8%.

Yearly Top and Bottom Value

HAFNIA LIMITED’s stock is valued at kr63.80 at 21:40 EST, under its 52-week high of kr65.90 and way above its 52-week low of kr19.20.

Volatility

HAFNIA LIMITED’s last week, last month’s, and last quarter’s current intraday variation average was 1.89%, 1.50%, and 2.02%.

HAFNIA LIMITED’s highest amplitude of average volatility was 2.76% (last week), 1.88% (last month), and 2.02% (last quarter).

More news about HAFNIA LIMITED.

Stay up to date with our winners and losers daily report